During the visit, Modi is also scheduled to attend the India-Australia CEOs Forum. (ANI photo) Nuclear power push: Prime Minister Narendra Modi’s visit to Australia this week may see a key uranium supply agreement being signed. It’s one of the key expected outcomes of PM Modi’s visit to Australia this week, as India seeks to...
Author: Source Author
Home
Source Author
Post
‘A good starting point’: Tuchel jokes Kane could ask Trump over Quansah’s red card
England head coach Thomas Tuchel reacts after the World Cup Round of 16 match against Mexico. (AP Photo) England head coach Thomas Tuchel has questioned FIFA’s decision to overturn Folarin Balogun’s World Cup suspension, joking that captain Harry Kane might have to call US President Donald Trump in an attempt to reverse Jarell Quansah’s red...
Post
July 6, 2026July 6, 2026Science & Tech
Why is red the colour of danger?
Red has the longest wavelength of any colour in the visible spectrum, so it is scattered the least by particles in the air, such as fog, rain or dust. Thus, you can see a red sign from further away than, say, one in blue or green. Humans are also hardwired to notice red. It is...
Post
PM Modi begins three-nation tour to Indonesia, Australia, New Zealand: What’s on agenda
NEW DELHI: Prime Minister Narendra Modi on Monday departed on a visit to Indonesia, Australia and New Zealand, reinforcing India’s Act East Policy.During his six-day visit to the three countries, the Prime Minister is expected to advance India’s “MAHASAGAR” vision and deepen the country’s commitment to a free, open and inclusive Indo-Pacific.“My visit to Indonesia...
Post
‘We’re not doing right with Sanju Samson’: Ex-India cricketer’s blunt verdict
India’s Sanju Samson (PTI Photo) Former India batter Aakash Chopra believes Rajat Patidar‘s return to India’s T20I side will have to wait, arguing that the current batting line-up leaves little room for the Royal Challengers Bengaluru captain despite his impressive performances.Patidar was not included in India’s 16-member squad for the ongoing five-match T20I series against...
Post
Apple not so ‘fruitful’ for Himachal? Climate pressures hill state’s Rs 5,000 cr economy
Himachal Pradesh’s 5,000 crore apple economy is facing a sharp climate squeeze this year, with unseasonal rains, hailstorms and erratic weather set to cut production by nearly 40%.Back in 2025, the state’s apple output stood at 6.99 lakh metric tonnes. However, in 2026, production is projected to decline by 2.63 lakh metric tonnes, or nearly...
Post
‘It absolutely stinks’: Football world erupts over Trump’s role in FIFA’s Balogun U-turn
Referee Raphael Claus shows a red card to United States’ Folarin Balogun (R). (AP Photo) FIFA’s unprecedented decision to suspend Folarin Balogun’s automatic one-match ban has ignited a fierce debate at the FIFA World Cup 2026, drawing criticism from rival teams and coaches even as the United States welcomed the move ahead of its Round...
Post
July 6, 2026July 6, 2026Science & Tech
How the amino acid leucine helps our cells produce energy
Proteins in the cells in our body perform functions of value to the sustenance and growth of organs. There are more than 20 amino acids, which are the building blocks of proteins, and the sequence of these amino acid chains generates the structure and function of each protein in the cells. Several of these amino...
Post
July 6, 2026July 6, 2026Science & Tech
Why isn’t one antivenom enough for India? | Explained
Gujarat has begun the process of developing a region-specific antivenom using venom collected from snakes found within the State. Why are scientists calling for geographically representative antivenoms? How is India’s existing antivenom made? And will region-specific products improve snakebite treatment? The story so far Gujarat has moved a step closer to developing its first region-specific...
Post
July 6, 2026July 6, 2026Science & Tech
Why FDA approval for vepdegestrant is a major shift in cancer therapy
On May 1, the U.S. Food and Drug Administration (FDA) approved the drug vepdegestrant for patients with ESR1-mutated, ER-positive, and HER2-negative advanced breast cancer. It is the world’s first therapy that the FDA — whose lead many drug regulators worldwide follow — has approved that is based on PROTAC technology. The approval paves the way...
